Dr. Darlene M Lee, M.D.,P.C. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-526-1112 |
Michael James Papez, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 1200 N Beaver Street, Flagstaff, AZ 86001 Phone: 928-773-2489 Fax: 928-773-2283 |
Forrest R Ritland, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 1200 N Beaver Street, Flagstaff, AZ 86001 Phone: 928-773-2489 Fax: 928-773-2283 |
Dr. Thomas E Vorpahl, M.D.,P.C. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-526-1112 |
News Archive
When treating cancer, it is an advantage to know the rate of growth of the cancer tumour. The standard method currently used to determine tumour growth, however, is erroneous. This is the conclusion of scientists at the University of Gothenburg, Sweden, who have developed a new model.
If you're scared to drink a cup of coffee out of fear that you'll spend the day in the restroom, you're not alone. Mild urinary frequency and urgency are common but for patients with urinary disorders, these same foods can provoke days of pain and discomfort. A new android application, the ICN Food List, seeks to change that by giving patients a reference guide that they can easily use while shopping and eating out at restaurants.
Delivering another innovation for interventional cardiology, Medtronic, Inc.,announced today the U.S. Food and Drug Administration (FDA) approval of the Integrity Coronary Stent System. The new platform for Medtronic's coronary stents, including the Integrity bare-metal stent, is based on an advance in biomedical engineering called continuous sinusoid technology that enables the exploration of other breakthrough device concepts such as a polymer free drug filled stent.
The Biotechnology Industry Organization (BIO) praised the Obama Administration for its new guidance, released today, that will lead to many small biotechnology companies receiving needed funding to support critical on-going research and development programs. The guidance document initiates the Therapeutic Discovery Project Program (TDPP), which was created by the Patient Protection and Affordable Care Act signed into law by President Obama on March 23.
› Verified 8 days ago